Gilead Sciences Inc (GILD)

Mexico
Currency in MXN
Disclaimer
1,290.00
0.00(0.00%)
Closed
Day's Range
1,290.001,290.00
52 wk Range
1,230.001,756.00
Prev. Close
1,320
Open
1,290
Day's Range
1,290-1,290
52 wk Range
1,230-1,756
Volume
0
Average Volume (3m)
824
1-Year Change
2.27%
Shares Outstanding
1,246,014,353
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
91.36
Upside +21.13%

People Also Watch

33.75
KHC
-0.82%
510.10
UNH
+1.26%
544.45
LLY
-0.97%
152.25
ABBV
-0.57%
106.15
ORCL
+1.46%

Gilead Sciences Inc Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc. and Tentarix Biotherapeutics Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Employees
17000

Income Statement